EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance

Raynier Zambrano-Villacres iD, Martín Campuzano-Donoso iD, Claudia Reytor-González iD, Gianluca Rossetti, Luigi Cobellis iD, Francesco Cobellis, Vincenzo Pilone, Daniel Simancas-Racines, Luigi Schiavo iD

Nutrients · 2026

DOI: 10.3390/nu18111751 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Raynier Zambrano-Villacres und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ciencias de la Salud y Desarrollo Humano, Universidad ECOTEC, Km. 13.5, Samborondón 092302, Ecuador. Hauptthemen laut MEDLINE: Incretins, Obesity, Glucagon-Like Peptide 1, Body Weight Maintenance. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 238 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists have transformed obesity treatment, producing substantial weight loss during active therapy. However, real-world effectiveness may be limited by gastrointestinal adverse events, reduced dietary intake, fat-free mass loss as part of total weight reduction, and weight regain after discontinuation.

Methods

This narrative review synthesizes current pharmacological, nutritional, gastrointestinal, body-composition, and implementation evidence to propose an evidence-informed nutrition-first framework for patients receiving incretin-based therapy for obesity.

Results

We translate pharmacologic mechanisms into practical dietary strategies, including protein prioritization, structured meal patterns, hydration and fiber management, symptom-targeted interventions, resistance-training support, and maintenance planning. Because direct trials of structured nutrition interventions in GLP-1RA- or dual incretin-treated populations remain limited, several recommendations are extrapolated from the broader obesity, caloric restriction, body-composition, gastrointestinal, and expert-consensus literature.

Conclusions

Integrating structured nutrition care into pharmacotherapy pathways may help address meal-related symptom burden, support protein and fluid adequacy, identify patients at higher nutritional or body-composition risk, and prepare patients for long-term weight-management behaviors. Embedding practical nutrition management within multidisciplinary obesity care may help translate pharmacologic efficacy into durable, patient-centered outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IncretinsObesityGlucagon-Like Peptide 1Body Weight MaintenanceHumansGlucagon-Like Peptide-1 Receptor AgonistsWeight LossGastric Inhibitory Polypeptide

Stichwörter der Autor:innen

GLP-1 receptor agonistdual incretin therapygastrointestinal tolerabilitylean body massnutrition therapyobesityprotein intakesemaglutidetirzepatideweight maintenance

Substanzen

IncretinsGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide 1Gastric Inhibitory Polypeptide

Autor:innen und Institutionen

  • Ciencias de la Salud y Desarrollo Humano, Universidad ECOTEC, Km. 13.5, Samborondón 092302, Ecuador.
  • Facultad de Ciencias de la Salud y Bienestar Humano, Universidad Tecnológica Indoamérica, Ambato 180150, Ecuador.
  • General and Bariatric Surgery Unit, Abano Terme Policlinic, 35031 Padova, Italy.
  • Unit of General Surgery, Casa Di Cura "Prof. Dott. Luigi Cobellis", 84078 Vallo della Lucania, Italy.
  • Public Health Department, University of Naples Federico II, 80131 Naples, Italy.
  • Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.

ORCID-Profile: Raynier Zambrano-Villacres, Martín Campuzano-Donoso, Claudia Reytor-González, Luigi Cobellis, Luigi Schiavo

Zitieren

APA

Zambrano-Villacres, R., Campuzano-Donoso, M., Reytor-González, C., Rossetti, G., Cobellis, L., Cobellis, F., Pilone, V., Simancas-Racines, D., & Schiavo, L. (2026). Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance. Nutrients. https://doi.org/10.3390/nu18111751

Vancouver

Zambrano-Villacres R, Campuzano-Donoso M, Reytor-González C, Rossetti G, Cobellis L, Cobellis F, et al. Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance. Nutrients. 2026. doi:10.3390/nu18111751

BibTeX
@article{ZambranoVillacres2026,
  author = {Zambrano-Villacres, Raynier and Campuzano-Donoso, Martín and Reytor-González, Claudia and Rossetti, Gianluca and Cobellis, Luigi and Cobellis, Francesco and Pilone, Vincenzo and Simancas-Racines, Daniel and Schiavo, Luigi},
  title = {Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18111751}
}
Kostenlos starten →